Full Press Release Details
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4).
RARE
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Key Takeaway: Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Price reaction · baseline $27.44 (2026-06-18 close) · hit after-hours · clean, no other RARE news in the window
day 0 close
+5.8%
day 1
+4.8%
day 3 · peak
+6.6%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+43%
120-day peak, hindsight
Typical move
2.9%
average across 6 past catalysts
Cash runway
~13 mo
Low dilution risk
Lead asset
BPS804
Phase 2 · Hypophosphatasia